1
|
Aguero D, Vest MH, Tryon J. The role of the chief pharmacy officer in leading analytics strategy to support the enterprise. Am J Health Syst Pharm 2024:zxae064. [PMID: 38469877 DOI: 10.1093/ajhp/zxae064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2024] [Indexed: 03/13/2024] Open
Abstract
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
Collapse
Affiliation(s)
- David Aguero
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA
| | - Mary-Haston Vest
- Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA
| | - Jennifer Tryon
- Community Care Services, Henry Ford Health, Bingham Farms, MI, USA
| |
Collapse
|
2
|
Eason BE, Vest TA, Mieure KD, Neal D, Tryon J. Evaluation and Enhancement of a Comprehensive Controlled Substances Management Process at an Academic Medical Center. J Pharm Pract 2023; 36:96-103. [PMID: 34132129 DOI: 10.1177/08971900211022286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
PURPOSE Controlled substances management is highly regulated, and requires institutions to have processes in place to maintain a closed-loop. This study was conducted to comprehensively evaluate the current state of controlled substances management, propose optimization opportunities, and implement steps to align the medication use process (MUP) to a defined desired state. METHODS This evaluation was conducted in 2 phases. In phase 1, the current state of controlled substances management was assessed in order to develop a gap analysis tool and failure mode and effects analysis (FMEA). In phase 2, a work group was assembled to address opportunities within the FMEA. The work group prioritized opportunities using the risk priority number (RPN), and formulated action steps to align processes with the defined desired state. RESULTS Through the literature evaluation, a desired state, consisting of 86 segments, was defined and compared with a gap analysis tool. Direct observation of the MUP allowed for development of 13 process maps depicting current state. Of the 86 segments, it was determined the study institution had a compliance rate of 62%. The remaining 38% correlated with 55 actionable process opportunities that were included in the FMEA. To date, 31 of the 55 (56%) opportunities have been successfully addressed by the work group. CONCLUSION Use of direct observation to formulate a gap analysis tool and FMEA is an effective modality to evaluate controlled substances processes. These tools allow for pharmacy departments to identify and prioritize opportunities to optimize controlled substances management within an academic medication center.
Collapse
Affiliation(s)
- Bailey E Eason
- Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.,University of Virginia Health, Charlottesville, VA, USA.,UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA
| | - Tyler A Vest
- UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA.,Duke University Hospital, Durham, NC, USA
| | | | - Danielle Neal
- Wake Forest Baptist Medical Center, Winston-Salem, NC, USA
| | - Jennifer Tryon
- Wake Forest Baptist Medical Center, Winston-Salem, NC, USA
| |
Collapse
|
3
|
Vermeulen LC, Swarthout MD, Alexander GC, Ginsburg DB, Pritchett KO, White SJ, Tryon J, Emmerich C, Nesbit TW, Greene W, Fox ER, Conti RM, Scott BE, Sheehy F, Melby MJ, Lantzy MA, Hoffman JM, Knoer S, Zellmer WA. ASHP Foundation Pharmacy Forecast 2020: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems. Am J Health Syst Pharm 2020; 77:84-112. [PMID: 31803902 DOI: 10.1093/ajhp/zxz283] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Lee C Vermeulen
- UK HealthCare, and Professor of Medicine and Pharmacy, University of Kentucky, Lexington, KY
| | - Meghan D Swarthout
- Ambulatory and Transitions of Care Services, Department of Pharmacy, Johns Hopkins Health System, Baltimore, MD
| | - G Caleb Alexander
- Professor of Epidemiology and Medicine, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD
| | - Diane B Ginsburg
- Pharmacy Practice Division, The University of Texas at Austin College of Pharmacy, Austin, TX
| | - Katie O Pritchett
- McCombs School of Business, The University of Texas at Austin College of Pharmacy, Austin, TX
| | - Sara J White
- Director of Pharmacy, Stanford Health, Palo Alto, CA
| | | | - Conrad Emmerich
- Senior Vice President of Operations, Wake Forest Baptist Health, Winston-Salem, NC
| | - Todd W Nesbit
- Director - Pharmacy Patient Care Services, The Johns Hopkins Health System, Baltimore, MD
| | - William Greene
- Chief Pharmaceutical Officer and Member, Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, TN
| | - Erin R Fox
- Drug Information and Support Services, University of Utah Health.,University of Utah College of Pharmacy, Salt Lake City, UT
| | - Rena M Conti
- Department of Markets, Public Policy and Law, Questrom School of Business, Boston University, Boston, MA
| | | | | | - Michael J Melby
- Director of Innovation and Activation, Indiana University Health, Indianapolis, IN
| | - Mark A Lantzy
- Senior Vice President and Chief Information Officer, Indiana University Health, and President, Indiana University Health Plans, Indianapolis, IN
| | - James M Hoffman
- Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
| | | | | |
Collapse
|
4
|
Abstract
Objective: To describe available compensated student internships and provide guidance for new program development. Methods: A search was conducted using PubMed, MEDLINE, and Google with the following search terms: pharmacy, intern, internship, and student. All English language publications were considered for inclusion. Articles describing IPPE or APPE student utilization were excluded. Key findings: Pharmacy student internship programs are common in practice, though there are few with published outcome data. Most often, interns serve as pharmacist extenders and participate in activities that center around extension of pharmacy services within the institution. Development of new programs should include partnering with nearby pharmacy programs and state boards of pharmacy to develop a well matched curriculum and allow for interns to practice at the top of their license. Lastly, outcomes should be measured and disseminated for the benefit of the academy. Additional considerations for developing a student internship program and guidance are provided. Conclusions: Although in existence for decades, minimal published reports showcase institutional outcomes associated with student internships. No data is available to show the downstream effect an internship can have on direct patient care activities.
Collapse
Affiliation(s)
- Sarah A Nisly
- Wingate University, Wingate, North Carolina.,Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
| | - Lisa F Brennan
- Wingate University, Wingate, North Carolina.,Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
| | | | | | - Jennifer Tryon
- Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
| |
Collapse
|
5
|
Saad F, Chi K, Shore N, Graff J, Posadas E, Freeman S, Tryon J, Trudel G, de Jong J, Meltzer J, Zhao X, Tran N, Rezazadeh A. Interim results of a phase Ib study of niraparib plus androgen receptor-targeted therapy in men with metastatic castration-resistant prostate cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy284.043] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
6
|
Wilson EC, Turner C, Arayasirikul S, Woods T, Nguyen T, Lin R, Franza K, Tryon J, Nemoto T, Iwamoto M. Housing and income effects on HIV-related health outcomes in the San Francisco Bay Area - findings from the SPNS transwomen of color initiative. AIDS Care 2018; 30:1356-1359. [PMID: 29920118 DOI: 10.1080/09540121.2018.1489102] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
Transwomen of color are disproportionately impacted by HIV and may have worse health outcomes than other populations. This analysis was conducted to examine structural factors associated with poor health outcomes among transwomen of color living with HIV in the San Francisco Bay Area (N = 159). Univariate and multivariable analyses were conducted to determine if structural factors were associated with poor HIV-related health outcomes. A majority of participants were Black or African American (110/159, 69.2%), 32 (20.1%) identified their primary race/ethnicity as Hispanic or Latino/a or Spanish, and 17 (10.7%) identified as another race/ethnicity. Transwomen of color in our sample faced extreme structural barriers, including residential transience, extreme low income, high prevalence of running out of money in the last six months, high rates of food insecurity, high prevalence of income via entitlement programs, engagement in sex work and other illicit activities for income. Unstable housing was the structural factor most consistently associated with poor health outcomes along the HIV care continuum and may explain engagement in other sources of income generation. Interventions are needed that go beyond the individual and health care-level to address needs for housing and economic opportunities to improve HIV care outcomes among transwomen of color living with HIV in the San Francisco Bay Area.
Collapse
Affiliation(s)
- E C Wilson
- a Center for Public Health Research, San Francisco Department of Public Health , San Francisco , California , USA
| | - C Turner
- a Center for Public Health Research, San Francisco Department of Public Health , San Francisco , California , USA
| | - S Arayasirikul
- a Center for Public Health Research, San Francisco Department of Public Health , San Francisco , California , USA
| | - T Woods
- b Brandy Martell Project, TransVision program, Tri City Health Center
| | - T Nguyen
- b Brandy Martell Project, TransVision program, Tri City Health Center
| | - R Lin
- a Center for Public Health Research, San Francisco Department of Public Health , San Francisco , California , USA
| | - K Franza
- c TransAccess Program, Asian and Pacific Islander Wellness Center and San Francisco Department of Public Health
| | - J Tryon
- c TransAccess Program, Asian and Pacific Islander Wellness Center and San Francisco Department of Public Health
| | - T Nemoto
- d Butterfly Nest, Public Health International
| | - M Iwamoto
- d Butterfly Nest, Public Health International
| |
Collapse
|
7
|
Farris KB, Kelly MW, Tryon J. Clock drawing test and medication complexity index as indicators of medication management capacity: a pilot study. ACTA ACUST UNITED AC 2013; 43:78-81. [PMID: 23945809 DOI: 10.1331/10865800360467097] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
8
|
Farris KD, Kelly MW, Tryon J. Clock drawing test and medication complexity index as indicators of medication management capacity: a pilot study. J Am Pharm Assoc (Wash) 2003; 43:78-81. [PMID: 12585756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Affiliation(s)
- Karen D Farris
- College of Pharmacy, University of Iowa, Iowa City 52242, USA.
| | | | | |
Collapse
|